CaHA Injectable for Facial Use Gains Regulatory Approval in China
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.
The expanded collaboration introduces preferred merchant rates for AmSpa’s members through Synchrony’s CareCredit credit card, offering AmSpa members savings when processing patient, customer, and client cardholder payments.